Join BIA for the inaugural transatlantic Women in Biotech - extend your networks globally, catch up with familiar faces, and help us to make a difference.
Whilst VCs in life sciences continue to put management teams that are ‘proven’ or known to them in place rather than backing diverse ones, later investment rounds will demand a broader, more diverse set of thinking to which companies need to adapt in order to attract more mature capital.
You'll discuss these challenges with a panel representing a range of different investment stages – from both investor and leadership perspectives - taking in points of view from both sides of the Atlantic and encouraging an interactive discussion around best practice and how we can affect change, asking “how do we encourage investors to back female-led/founded companies and diverse leadership teams from company inception?”.
With their charity partner of the year, Ovarian Cancer Action, BIA is supporting Ovarian Cancer Awareness month at this Women in Biotech event. Cary Wakefield, CEO of Ovarian Cancer Action, will join to give a few words at the start of the event. Additionally, BIA will be donating £10 per ticket sold for the event to Ovarian Cancer Action.